Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin for Prevention of Surgical Site Infection After Cesarean Section
NCT07311395Recruiting
- Sponsor
- Galilee Medical Center
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
Randomised trial in surgical site infection (SSI) comparing Local subcutaneous gentamicin with Local subcutaneous placebo (saline) (2 arms). Primary endpoint: Composite wound complication at 30 days. Started Dec 2025; status: recruiting.
02
Drugs
gentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07311395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311395.